Dilip H. Vallathol

Cochin, KL, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Challenges in Targeting the "Crosstalks" in Cancer Cachexia.

Challenges in Targeting the "Crosstalks" in Cancer Cachexia.

Journal: South Asian journal of cancer

Published: July 30, 2024

Outcomes of non-metastatic triple negative breast cancers: Real-world data from a large Indian cohort.

Outcomes of non-metastatic triple negative breast cancers: Real-world data from a large Indian cohort.

Journal: Breast (Edinburgh, Scotland)

Published: February 15, 2022

RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation.

RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation.

Journal: Oral oncology

Published: August 23, 2021

Leptomeningeal metastasis from non-small cell lung cancer- a post-hoc analysis from four randomised clinical trials.

Leptomeningeal metastasis from non-small cell lung cancer- a post-hoc analysis from four randomised clinical trials.

Journal: Ecancermedicalscience

Published: August 21, 2021

Thromboembolic events in brain tumour patients on bevacizumab.

Thromboembolic events in brain tumour patients on bevacizumab.

Journal: Acta oncologica (Stockholm, Sweden)

Published: September 08, 2020

Safety and efficacy of bevacizumab biosimilar in recurrent/ progressive glioblastoma.

Safety and efficacy of bevacizumab biosimilar in recurrent/ progressive glioblastoma.

Journal: Ecancermedicalscience

Published: September 05, 2020

Lutetium 177 dotatate induced acute myeloid leukemia.

Lutetium 177 dotatate induced acute myeloid leukemia.

Journal: Leukemia & lymphoma

Published: July 28, 2020

Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial.

Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial.

Journal: The Lancet. Global health

Published: March 18, 2020

Calculation of a clinical predictive factors identifying peritoneal disease on a staging laparoscopy in gastric cancers.

Calculation of a clinical predictive factors identifying peritoneal disease on a staging laparoscopy in gastric cancers.

Journal: South Asian journal of cancer

Published: September 07, 2019

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.

Journal: Cancer

Published: January 20, 2019

Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer.

Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer.

Journal: EClinicalMedicine

Published: October 24, 2018

Antiemetic prophylaxis with temozolomide: an audit from a tertiary care center.

Antiemetic prophylaxis with temozolomide: an audit from a tertiary care center.

Journal: Neuro-oncology practice

Published: October 05, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026